| Health / Medical Topics |
Conatumumab
A fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor 2 (TR-2) with potential antineoplastic activity. Conatumumab mimics the activity of native TRAIL, binding to and activating TR-2, thereby activating caspase cascades and inducing tumor cell apoptosis. TR-2 is expressed by a variety of solid tumors and cancers of hematopoietic origin. (NCI Thesaurus)
YOU MAY ALSO LIKE
The conscious tendency to act, usually an aspect of mental process.
Any of the commercial combination preparations, by Novartis, containing a combination of any of the following agents: the analgesic antipyretic acetaminophen, an…
Human COMT wild-type allele is located in the vicinity of 22q11.21 and is approximately 27 kb in length. This allele, which encodes…
This gene is involved in the metabolism of catecholamine drugs and neurotransmitters.
NIH Emphasis Area -- Recent advances in basic biology, genetics, diagnosis, and health care have all been closely linked to the development…
A series of detailed pictures of areas inside the body taken from different angles. The pictures are created by a computer linked…
